2005年4月第4期
·07/06/08 Clinical management of spasticity
·07/06/08 Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
·07/06/08 Comparison of Bobath based and movement science based treatment for stroke: a randomised controlled trial
·07/06/08 Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia
·07/06/08 Clinical significance of detection of multiple acute brain infarcts on diffusion weighted magnetic resonance imaging
·07/06/08 Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
·07/06/08 Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression
·07/06/08 Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit
·07/06/08 Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system
·07/06/08 Detection of focal cerebral hemisphere lesions using the neurological examination
·07/06/08 A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons
·07/06/08 Cerebral revascularisation: where are we now?
·07/06/08 Views of bereaved relatives about quality of survival after radiotherapy for malignant cerebral glioma
·07/06/08 Facets and determinants of quality of life in patients with recurrent high grade glioma
·07/06/08 The effect of subthalamic nucleus stimulation on kinaesthesia in Parkinson’s disease
·07/06/08 Linear high intensity area along the medial margin of the internal segment of the globus pallidus in Machado-Joseph disease patients
·07/06/08 Interferon alfa treatment for Sj?gren’s syndrome associated neuropathy
·07/06/08 Autonomic neuropathy and coeliac disease
·07/06/08 Diseases of the nervous system: patients’ aetiological beliefs
·07/06/08 The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study
·07/06/08 Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy
·07/06/08 Six novel NPC1 mutations in Chinese patients with Niemann–Pick disease type C
·07/06/08 Physiotherapy after stroke: define, divide and conquer
·07/06/08 A case of late onset sporadic Parkinson’s disease with an A53T mutation in -synuclein
·07/06/08 Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury
·07/06/08 A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons
·07/06/08 Severe malaria: still counting the costs
·07/06/08 Depression in multiple sclerosis: a review
·07/06/08 Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children
·07/06/08 Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson’s disease
·07/06/08 Cognitive behavioural therapy (CBT) for carers of patients with Parkinson’s disease: a preliminary randomised controlled trial
·07/06/08 Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
·07/06/08 Comparison of Bobath based and movement science based treatment for stroke: a randomised controlled trial
·07/06/08 Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia
·07/06/08 Clinical significance of detection of multiple acute brain infarcts on diffusion weighted magnetic resonance imaging
·07/06/08 Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
·07/06/08 Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression
·07/06/08 Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit
·07/06/08 Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system
·07/06/08 Detection of focal cerebral hemisphere lesions using the neurological examination
·07/06/08 A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons
·07/06/08 Cerebral revascularisation: where are we now?
·07/06/08 Views of bereaved relatives about quality of survival after radiotherapy for malignant cerebral glioma
·07/06/08 Facets and determinants of quality of life in patients with recurrent high grade glioma
·07/06/08 The effect of subthalamic nucleus stimulation on kinaesthesia in Parkinson’s disease
·07/06/08 Linear high intensity area along the medial margin of the internal segment of the globus pallidus in Machado-Joseph disease patients
·07/06/08 Interferon alfa treatment for Sj?gren’s syndrome associated neuropathy
·07/06/08 Autonomic neuropathy and coeliac disease
·07/06/08 Diseases of the nervous system: patients’ aetiological beliefs
·07/06/08 The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study
·07/06/08 Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy
·07/06/08 Six novel NPC1 mutations in Chinese patients with Niemann–Pick disease type C
·07/06/08 Physiotherapy after stroke: define, divide and conquer
·07/06/08 A case of late onset sporadic Parkinson’s disease with an A53T mutation in -synuclein
·07/06/08 Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury
·07/06/08 A failure to communicate: patients with cerebral aneurysms and vascular neurosurgeons
·07/06/08 Severe malaria: still counting the costs
·07/06/08 Depression in multiple sclerosis: a review
·07/06/08 Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children
·07/06/08 Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson’s disease
·07/06/08 Cognitive behavioural therapy (CBT) for carers of patients with Parkinson’s disease: a preliminary randomised controlled trial